Antonio Passaro: Honored to be Recognized Among Leaders Shaping Oncology in 2024
Antonio Passaro, Medical oncologist at the European Institute of Oncology in Milan, shared a post on LinkedIn:
“Honored to be included among such outstanding colleagues shaping the future of medical oncology.
Advancing research and improving patient care is a collective effort, and I’m proud to contribute alongside these incredible minds. Thank you for this recognition—it inspires us to keep pushing boundaries for a brighter future in oncology.”
Mediamedic stated in the original post:
’As 2024 draws to a close, we are proud to recognize outstanding professors whose contributions have shaped the field of oncology. From innovative treatments to advancing research and improving patient care, their work exemplifies excellence and dedication to progress.
Their tireless efforts inspire hope, transform lives, and lay the foundation for a brighter future in oncology. Join us in celebrating these remarkable achievements.
Our journey to honor the leaders in oncology continues—stay tuned for more tributes to the exceptional minds driving advancements in cancer care worldwide.’”
More posts featuring Antonio Passaro.
Antonio Passaro MD PhD, a medical oncologist at the European Institute of Oncology in Milan, specializes in lung cancer research and treatment. He focuses on developing new therapies, including immunotherapy, and identifying reliable biomarkers for non-small cell lung cancer (NSCLC).
Dr. Antonio Passaro is an Associate Editor for Lung Cancer Journal by Elsevier and the Chair of the ESMO Press & Media Affairs Committee.
He is also a faculty member for the Lung and Other Thoracic Tumours faculty group and the ESMO-MCBS Extended Working Group. He also holds editorial positions and key roles in societies like ESMO and AIOM.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023